[Clinical and experimental studies with the antihistaminic Tavegyl in dermatologic patients].
作者信息
Grabner K
出版信息
Wien Klin Wochenschr. 1970 Sep 4;82(36):625-7.
PMID:4396798
Abstract
摘要
相似文献
1
[Clinical and experimental studies with the antihistaminic Tavegyl in dermatologic patients].[抗组胺药曲吡那敏在皮肤科患者中的临床与实验研究]
Wien Klin Wochenschr. 1970 Sep 4;82(36):625-7.
2
[Clinical and allergological evaluation of Tavegil (HS-592), a new antihistaminic drug].新型抗组胺药 Tavigil（HS - 592）的临床及变应性评估
Przegl Dermatol. 1969 Sep-Oct;56(5):659-65.
3
[Experience with the Tavegil therapy of chronic pruritic dermatoses].[特非那定治疗慢性瘙痒性皮肤病的经验]
Sov Med. 1972 Apr;35(4):124-6.
4
[Experience with a new antihistaminic in dermatology. Results of a clinical double blind trial].[一种新型抗组胺药在皮肤科的应用经验。一项临床双盲试验的结果]
Wien Med Wochenschr. 1969 Sep 20;119(38):630-2.
5
A new antihistaminic drug (Tavegyl) in allergic diseases.
Ther Hung. 1971;19(2):67-9.
6
[The antihistaminic Tavegil--therapeutic test for the role of histamine in dermatoses].[抗组胺药 Tavigil——组胺在皮肤病中作用的治疗性试验]
Med Welt. 1967 Sep 2;35:2054-7.
7
[Experience with an oral corticoid-antihistaminic combination in dermatological practice].[口服皮质类固醇-抗组胺药联合用药在皮肤科实践中的经验]
Berufsdermatosen. 1968 Jun;16(3):164-9.
8
[Trial of clinical evaluation of Doxergan, a new antihistaminic drug].[新型抗组胺药多克根的临床评价试验]
Przegl Dermatol. 1968 May-Jun;55(3):349-55.
9
[Clinical experience with a new antihistaminic].[一种新型抗组胺药的临床经验]
Wien Med Wochenschr. 1967 Sep 23;117(38):868-70.
10
[Therapeutic evaluation of a new antihistaminic: HS-592].
Hospital (Rio J). 1968 Nov;74(5):1511-4.
引用本文的文献
1
Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema.口服H1抗组胺药作为湿疹局部治疗的“附加”疗法。
Cochrane Database Syst Rev. 2019 Jan 22;1(1):CD012167. doi: 10.1002/14651858.CD012167.pub2.
2
Interventions for treating scabies.治疗疥疮的干预措施。
Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD000320. doi: 10.1002/14651858.CD000320.pub2.
Zotero 插件